Literature DB >> 8307555

Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23.

W J Kimberling1, S Kumar, P A Gabow, J B Kenyon, C J Connolly, S Somlo.   

Abstract

At least two loci are known to exist for autosomal dominant polycystic kidney disease (ADPKD). One was localized to 16p, but the second less common locus has remained unlinked. Over 100 microsatellite markers, distributed across all chromosomes, have been typed on informative family members from the large Sicilian kindred in which the genetic heterogeneity was first discovered. Both the affected and the unaffected status of every family member used in the study were confirmed by renal ultrasonography. This search has resulted in the successful localization of a second ADPKD gene to chromosome 4q. It was found to be flanked by the markers D4S231 and D4S414, defining a segment that spans about 9 cM. The new locus has been designated PKD4. This second localization will allow researchers to target another ADPKD gene for isolation in an effort to understand the pathogenesis of this common disorder. Furthermore, when flanking markers for the second ADPKD gene are used in conjunction with flanking markers for PKD1, the accuracy of the diagnosis of the subtype of ADPKD present in any particular family will be enhanced. This will improve the accuracy of linkage-based presymptomatic diagnoses by reducing the error due to genetic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307555     DOI: 10.1016/s0888-7543(11)80001-7

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  57 in total

1.  A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes.

Authors:  M Ariza; V Alvarez; R Marín; S Aguado; C López-Larrea; J Alvarez; M J Menéndez; E Coto
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2).

Authors:  B Veldhuisen; J J Saris; S de Haij; T Hayashi; D M Reynolds; T Mochizuki; R Elles; R Fossdal; N Bogdanova; M A van Dijk; E Coto; D Ravine; S Nørby; C Verellen-Dumoulin; M H Breuning; S Somlo; D J Peters
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

Review 3.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

Review 4.  Formins and microtubules.

Authors:  F Bartolini; G G Gundersen
Journal:  Biochim Biophys Acta       Date:  2009-07-23

Review 5.  Polycystic kidney disease--a truly pediatric problem.

Authors:  M R Ogborn
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

6.  Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein.

Authors:  O Ibraghimov-Beskrovnaya; W R Dackowski; L Foggensteiner; N Coleman; S Thiru; L R Petry; T C Burn; T D Connors; T Van Raay; J Bradley; F Qian; L F Onuchic; T J Watnick; K Piontek; R M Hakim; G M Landes; G G Germino; R Sandford; K W Klinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

7.  Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2.

Authors:  L Tsiokas; E Kim; T Arnould; V P Sukhatme; G Walz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

8.  Genetic heterogeneity in adult dominant polycystic kidney disease in Cypriot families.

Authors:  C D Constantinou-Deltas; E Papageorgiou; K Boteva; K Christodoulou; M H Breuning; D J Peter; A Pierides
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

9.  Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.

Authors:  C J Ward; H Turley; A C Ong; M Comley; S Biddolph; R Chetty; P J Ratcliffe; K Gattner; P C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 10.  Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors:  O Ibraghimov-Beskrovnaya; N Bukanov
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.